Alzamend Neuro (ALZN) Earnings Date & Reports

Alzamend Neuro Inc is an early clinical-stage biopharmaceutical company... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

ALZN is expected to report earnings to fall 73.68% to -5 cents per share on January 03

Alzamend Neuro ALZN Stock Earnings Reports

Q4'23

Est.

$-0.05

Q1'25

Beat

by $0.41

Q3'23

Missed

by $0.56

Q2'23

Missed

by $0.42

Q1'23

Missed

by $0.86

The last earnings report on March 10 showed earnings per share of -18 cents, beating the estimate of -60 cents. With 14.79K shares outstanding, the current market capitalization sits at 4.55M.

View a ticker or compare two or three

Compare

ALZN

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For ALZN
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

3480 Peachtree Road NE

Phone

+1 844 722-6333

Employees

Web

https://www.alzamend.com